{"id":27943,"date":"2021-10-26T14:42:40","date_gmt":"2021-10-26T12:42:40","guid":{"rendered":"https:\/\/www.satt.fr\/satt-up-octobre-2021\/"},"modified":"2021-10-26T14:42:40","modified_gmt":"2021-10-26T12:42:40","slug":"satt-up-octobre-2021","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021"},"content":{"rendered":"
\n
\n\t

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #SATTUP.<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div>

\n
\n\t

ACTICOR BIOTECH lance son introduction en bourse sur Euronext Growth \u00e0 Paris. <\/strong>(Ouest Valorisation)<\/em><\/p>\n

ACTICOR BIOTECH, une entreprise de biotechnologie au stade clinique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de m\u00e9dicaments pour le traitement des urgences cardio-vasculaires, annonce le lancement de son introduction en bourse en vue de l'admission aux n\u00e9gociations de ses actions sur le march\u00e9 Euronext Growth Paris. ACTICOR BIOTECH d\u00e9veloppe un m\u00e9dicament \u00ab first-in-class \u00bb pour traiter les urgences cardiovasculaires, dont l\u2019Accident Vasculaire C\u00e9r\u00e9bral (AVC) isch\u00e9mique.<\/p>\n

www.acticor-biotech.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

MECAWARE l\u00e8ve un premier tour de table de 2,5 millions d\u2019euros pour la production de ses \u00ab lingots verts \u00bb.<\/strong> (PULSALYS)<\/em><\/p>\n

Spin-off de l\u2019ICBMS (Lyon), la greentech MECAWARE est sp\u00e9cialis\u00e9e dans le recyclage des batteries \u00e9lectriques. La lev\u00e9e de fonds r\u00e9alis\u00e9e aupr\u00e8s d\u2019UI Investissement, KREAXI, EIT Inno Energy, BNP Paribas D\u00e9veloppement, Cr\u00e9dit Agricole Cr\u00e9ation et le r\u00e9seau Arts et M\u00e9tiers Business Angels avec le soutien de BPI France et de BNP Paribas, banque historique de la soci\u00e9t\u00e9, va permettre d\u2019acc\u00e9l\u00e9rer la construction d\u2019un premier site pilote.<\/p>\n

www.satt.fr\/mecaware<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

Dextrain : Le Manipulandum de Dextrain se distingue et re\u00e7oit 2 prix d\u2019innovation.<\/strong> (Erganeo)<\/em><\/p>\n

ARCHOS et sa filiale Medical Devices Venture, premier actionnaire de Dextrain, sont fi\u00e8res d\u2019annoncer que le projet de la startup Dextrain \u00ab Evaluation et r\u00e9\u00e9ducation de la dext\u00e9rit\u00e9 manuelle apr\u00e8s un AVC\u00bb a re\u00e7u le Prix du Concours Innovation Handicap SOFMER 2021 offert et soutenu par la Soci\u00e9t\u00e9 Thuasne.<\/p>\n

dextrain.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

Maat Pharma se lance en Bourse et esp\u00e8re lever entre 35 et 46 millions d\u2019euros. <\/strong>(LUTECH)<\/em><\/p>\n

Apr\u00e8s avoir lev\u00e9 25 millions d\u2019euros en 2020, le sp\u00e9cialiste fran\u00e7ais du microbiote, MaaT Pharma a annonc\u00e9 son introduction en Bourse sur le march\u00e9 r\u00e9glement\u00e9 d\u2019Euronext Paris. Avec cette introduction, la biotech esp\u00e8re poursuivre le d\u00e9veloppement de m\u00e9dicaments de nouvelle g\u00e9n\u00e9ration issus d\u2019\u00e9cosyst\u00e8mes bact\u00e9riens complets, avec le lancement de la phase III de son principal candidat-m\u00e9dicament avant la fin de l\u2019ann\u00e9e.<\/p>\n

www.maatpharma.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

ARCHOS annonce la cr\u00e9ation de la soci\u00e9t\u00e9 Poladerme, filiale de Medical Devices Venture.<\/strong>(Conectus)<\/em><\/p>\n

ARCHOS annonce la cr\u00e9ation de la soci\u00e9t\u00e9 Poladerme, d\u00e9tenue ce jour \u00e0 40% par Medical Devices Venture, une filiale d\u2019ARCHOS. L\u2019ambition de la startup Poladerme est de devenir un leader de la spectropolarim\u00e9trie combin\u00e9e \u00e0 l\u2019Intelligence Artificielle et au machine learning, appliqu\u00e9 \u00e0 la dermatologie.<\/p>\n

www.conectus.fr\/poladerme<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

GlioCure obtient un financement \u00ab Pays-de-la-Loire Innovation-PIA3 \u00bb pour le d\u00e9veloppement de son portefeuille de produits en neuro-oncologie.<\/strong> (Ouest Valorisation)<\/em><\/p>\n

GlioCure SA, soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e en neuro-oncologie, annonce aujourd\u2019hui l\u2019obtention d\u2019une aide de 336.000 \u20ac, sous forme d\u2019avances remboursables, en r\u00e9ponse \u00e0 l\u2019appel \u00e0 projets \u00ab Pays-de-la-Loire Innovation-PIA3 \u00bb pour son projet intitul\u00e9 \u00ab GC01 vs GC04 : choix du meilleur candidat-m\u00e9dicament pour les traitements des gliomes de haut grade \u00bb.<\/p>\n

www.gliocure.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

Qubit Pharmaceuticals re\u00e7oit le prix EIC Acc\u00e9l\u00e9rateur 2021. <\/strong>(LUTECH)<\/em><\/p>\n

R\u00e9compens\u00e9e par le prix i-Lab 2020, Qubit Pharmaceuticals, une suite logicielle exploitant la puissance de calcul des futurs ordinateurs quantiques pour d\u00e9velopper de nouveaux m\u00e9dicaments, re\u00e7oit le prix EIC acc\u00e9l\u00e9rateur 2021. Cette suite logicielle, est la plus pr\u00e9cise et la plus rapide au monde pour am\u00e9liorer la d\u00e9couverte de m\u00e9dicaments via la mod\u00e9lisation in silico des interactions mol\u00e9culaires, premier maillon de toute la cha\u00eene de valeur de l\u2019industrie pharmaceutique.<\/p>\n

qubit-pharmaceuticals.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

Lys Therapeutics, Laur\u00e9at et Grand Prix du concours d\u2019innovation i-Lab, acc\u00e9l\u00e8re ses recherches sur son anticorps monoclonal Glunozumab\u00ae. <\/strong>(PULSALYS)<\/em><\/p>\n

Lys Therapeutics, soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise d\u00e9veloppant des th\u00e9rapies innovantes contre les maladies neurologiques annonce aujourd\u2019hui avoir re\u00e7u une subvention de 600 000 euros en tant que Laur\u00e9at et Grand Prix du Concours d\u2019innovation i-Lab pour son candidat-m\u00e9dicament Glunozumab\u00ae.<\/p>\n

lystherapeutics.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div>
\n
\n\t

PEP-Therapy et l\u2019Institut Curie annoncent le traitement des premiers patients avec PEP-010 dans un essai clinique de Phase I pour les tumeurs solides avanc\u00e9es. <\/strong>(LUTECH)<\/em><\/p>\n

PEP-Therapy, soci\u00e9t\u00e9 clinique de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de peptides p\u00e9n\u00e9trants comme th\u00e9rapies cibl\u00e9es en oncologie, et l'Institut Curie, acteur de r\u00e9f\u00e9rence de la lutte contre le cancer, annoncent le traitement des premiers patients de l\u2019essai clinique de Phase Ia\/b multicentrique \u00e9valuant PEP-010, le candidat m\u00e9dicament de PEP-Therapy. Dans ce premier essai clinique chez l\u2019homme, PEP-010 est administr\u00e9 \u00e0 des patients atteints de tumeurs solides avanc\u00e9es.<\/p>\n

pep-therapy.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div>

\"\"<\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #SATTUP. ACTICOR BIOTECH lance son introduction en bourse sur Euronext Growth \u00e0 Paris. (Ouest Valorisation) ACTICOR BIOTECH, une entreprise de biotechnologie au stade clinique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de m\u00e9dicaments pour le traitement des urgences cardio-vasculaires, annonce le lancement de son introduction […]<\/p>\n","protected":false},"author":2,"featured_media":25224,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-27943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"\nSATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021\",\"datePublished\":\"2021-10-26T12:42:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/\"},\"wordCount\":896,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/sattup2.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/sattup2.jpg\",\"datePublished\":\"2021-10-26T12:42:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/sattup2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/sattup2.jpg\",\"width\":2560,\"height\":1428},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-octobre-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021","datePublished":"2021-10-26T12:42:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/"},"wordCount":896,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/05\/sattup2.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/","url":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/","name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/05\/sattup2.jpg","datePublished":"2021-10-26T12:42:40+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/05\/sattup2.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/05\/sattup2.jpg","width":2560,"height":1428},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT #27 \u2013 Octobre 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/27943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=27943"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/27943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/25224"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=27943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=27943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=27943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}